SeaCrest Wealth Management’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

SeaCrest Wealth Management’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$376K	Sell	22,518 -929	-4%	-$15K	0.04%	351
2026 Q2	$360K	Sell	23,447 -3,176	-12%	-$45.7K	0.04%	371
2026 Q1	$382K	Sell	26,623 -2,228	-8%	-$33.1K	0.04%	405
2025 Q4	$449K	Buy	28,851 +304	+1%	+$4.56K	0.05%	347
2025 Q3	$428K	Buy	28,547 +1,747	+7%	+$24.8K	0.05%	349
2025 Q2	$382K	Buy	26,800 +2,245	+9%	+$32.1K	0.04%	389
2025 Q1	$366K	Buy	+24,555	New	+$384K	0.04%	418

Other funds holding BMEZ

Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return

Apollon Wealth Management Mount Pleasant, South Carolina $8.72B AUM 23.07% 1-Year Est. Return

Indivisible Partners Clearwater, Florida $2.18B AUM 33.61% 1-Year Est. Return

Brown, Lisle/Cummings Providence, Rhode Island $453M AUM 20.23% 1-Year Est. Return

NWF Advisory Services Los Angeles, California $1.07B AUM 35.62% 1-Year Est. Return

PMG Family Office Plano, Texas $108M AUM 8.93% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Chapin Davis Baltimore, Maryland $520M AUM 117.57% 1-Year Est. Return

Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.3% 1-Year Est. Return

Independent Financial Group San Diego, California $5.51B AUM 33.51% 1-Year Est. Return

SeaCrest Wealth Management's BMEZ Position: Q3 2026 in Review

SeaCrest Wealth Management reduced its BlackRock Health Sciences Trust II (BMEZ) stake by 4% in Q3 2026, selling an estimated $15K and leaving 22,518 shares worth $376K. The position accounts for 0.04% of the portfolio, ranked #351.

SeaCrest Wealth Management first reported a position in BMEZ in Q1 2025 and has held it in 7 quarters since. The position peaked at $449K in Q4 2025. 15 funds tracked by Wall St. Rank hold BMEZ as of Q3 2026.

SeaCrest Wealth Management held 22,518 shares of BlackRock Health Sciences Trust II worth $376K as of Q3 2026.
SeaCrest Wealth Management sold 929 BlackRock Health Sciences Trust II shares in Q3 2026, an estimated $15K.
BlackRock Health Sciences Trust II made up 0.04% of SeaCrest Wealth Management's portfolio in Q3 2026, its #351 holding.
SeaCrest Wealth Management first reported a position in BlackRock Health Sciences Trust II in Q1 2025 and has held it in 7 quarters since.
SeaCrest Wealth Management's BlackRock Health Sciences Trust II position peaked at $449K in Q4 2025.
15 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2026.

Based on SeaCrest Wealth Management's 13F filing for Q3 2026, filed 21 Oct 2026.